The Latest
Private Equity

Co-investment, diversification drive CalPERS’ PE push

Since taking on the job of head of private equity at CalPERS two years ago Greg Ruiz has spent considerable time getting the portfolio back on track, understanding the positions and allocating capital. Now as the fund almost certainly will allocate more assets to private equity as part of a new asset allocation, Ruiz is looking to add to the sectors where the fund is underweight including venture.
Investor Profile

Florida SBA’s venture adventure

The Florida State Board of Administration’s (SBA) commitment to venture capital over many decades has been a contributor to the fund's performance. Last year the team had 340 meetings and calls, reviewed 109 funds, carried out due diligence on 26 and invested in three. Successful IPOs and SPACs, plus realisations from investments made in 2013/14, have led to a standout performance.
Net zero portfolios

Finding alpha: Church Commissioners outperform

The £9.2 billion portfolio managed for the Church Commissioners for England has returned 9.7 per cent over 10 years through a focus on sustainability and a willingness to try things early, such as forestry and venture capital. Amanda White spoke to CIO Tom Joy about where the fund looks for alpha and the need for a non-traditional allocation.
Featured Story

City of Austin looks to the future

The City of Austin Employees Retirement System has turned around its five-year performance with a focus on value in active management and deconstructing its bond portfolio. As it looks to the future CIO David Veal considers venture capital and crypto investments.
Technology

Back VC to solve inequalities: Ming

Pension funds around the globe should be putting their high-risk capital towards supporting venture funds that have a track record of seeing value in people, according to Vivienne Ming, Silicon Valley technologist, entrepreneur and theoretical neuroscientist. Ming believes that AI can be used to solve poverty, mental health, inequality and even predict who will spread COVID-19. She says technology can make all of our lives better.
FIS Harvard 2019

Biomedicine’s long and risky road

Startlingly few institutional investors have allocations to life sciences. An informal poll of 85 asset owners from 20 countries responsible for a combined $9 trillion assets under management gathered at the Fiduciary Investors’ Symposium at Harvard University, found only a tiny handful active in the sector. Yet allocating to biotech makes an important contribution to society - investing in the sector can help change lives.
<1of3>